MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 591500 | Name: AHR-6293

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AHR-6293 is used to distinguish the effect of anti-platelet aggregating drug properties from the effect of anti-inflammatory properties.

Chemical Structure

AHR-6293
AHR-6293
CAS#61941-63-7

Theoretical Analysis

MedKoo Cat#: 591500

Name: AHR-6293

CAS#: 61941-63-7

Chemical Formula: C15H11ClNNaO3

Exact Mass: 311.0325

Molecular Weight: 311.70

Elemental Analysis: C, 57.80; H, 3.56; Cl, 11.37; N, 4.49; Na, 7.38; O, 15.40

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
AHR-6293; AHR-6293; AHR-6293
IUPAC/Chemical Name
Benzeneacetic acid, 2-amino-3-(4-chlorobenzoyl)-, monosodium salt
InChi Key
FVBKCOXGVZPEDP-UHFFFAOYSA-M
InChi Code
InChI=1S/C15H12ClNO3.Na/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19;/h1-7H,8,17H2,(H,18,19);/q;+1/p-1
SMILES Code
O=C([O-])CC1=CC=CC(C(C2=CC=C(Cl)C=C2)=O)=C1N.[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 311.70 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Walsh DA, Moran HW, Shamblee DA, Welstead WJ Jr, Nolan JC, Sancilio LF, Graff G. Antiinflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid. J Med Chem. 1990 Aug;33(8):2296-304. PubMed PMID: 2115589. 2: Rosenblum WI. Unsaturated fatty acids and cyclooxygenase inhibitors: effects on pial arterioles. Am J Physiol. 1982 Apr;242(4):H629-32. PubMed PMID: 6801999. 3: Rosenblum WI, El-Sabban F. Use of AHR-5850 and AHR-6293 to distinguish the effect of anti-platelet aggregating drug properties from the effect of anti-inflammatory properties on an in vivo model of platelet aggregation. Microvasc Res. 1979 May;17(3 Pt 1):309-13. PubMed PMID: 459942.